Search keyWord :

InventisBio Announces Positive Phase 2 Study Results for D-2570 (TYK2 Inhibitor) in Patients with Moderate to Severe Plaque Psoriasis

Dec 4, 2024

– D-2570 demonstrates robust efficacy and favorable safety profile,achieving skin clearance comparable to leading biologics –

The Heavenly Voice That Inspires: Ani Bond: Choying Drolma Captivates Hong Kong Audiences; Screenings Extended Until 09 December

Dec 4, 2024

HONG KONG,Dec. 3,2024--On the evening of 30 November,Hong Kong\'s Premiere Elements hosted the highly anticipated premiere of Ani Bond: Choying Drolma. This musical documentary film chronicles the ext

AC Health makes critical HIV care more accessible to Filipinos with USAID support

Dec 4, 2024

MANILA,Philippines,Dec. 3,2024-- Ayala Healthcare Holdings,Inc. (AC Health),in partnership with the U.S. Agency for International Development (USAID),is leading the private sector\'s efforts to fight

ZEISS Debuts MYO 200 Biometer for Myopia Management in Hong Kong, Built on ZEISS "Gold Standard" Technology to Safeguard the Visual Health of Children and Adolescents

Dec 4, 2024

HONG KONG,Dec. 3,2024-- Global optical technology leaderZEISS debuted the ZEISS MYO 200 Biometer for Myopia Management in Hong Kong on November 28th,to provide more precise myopia control and improved

Pfizer Receives Authorization from Health Authority for Its 20-valent Pneumococcal Conjugate Vaccine for Infants and Children

Dec 4, 2024

In Hong Kong,the 20-valent Pneumococcal Conjugate Vaccine (PCV20) that offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine – helping to fight against 20 serotypes l

Hyundai Motor Shifts Perceptions by Unveiling All-Electric IONIQ 9 SUV at Iconic Goldstein House in LA

Dec 4, 2024

IONIQ 9 strengthens Hyundai Motor\'s position in the global EV market as the brand\'s first three-row electric SUV

Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter

Dec 4, 2024

– Provides interventionalists with optimal product choices for more complex radial-to-peripheral procedures –

Nature's Miracle Holding Inc. Appoints New Chief Financial Officer and Chief Operating Officer

Dec 4, 2024

ONTARIO,Calif.,Dec. 3,2024-- Nature\'s Miracle Holding Inc. (NASDAQ: NMHI) ("Nature\'s Miracle" or the "Company"),a leader in vertical farming technology and infrastructure,announc

Vale Base Metals complete Voisey's Bay transition to underground mining

Dec 4, 2024

TORONTO,Dec. 3,2024-- Vale Base Metals has completed construction and commissioning of its US$2.94 billionVoisey\'s Bay Mine Expansion Project in northern Labrador,a major milestone that will increas

Samsung Biologics hosts ESG event with suppliers to strengthen decarbonization efforts

Dec 4, 2024

INCHEON,South Korea,Dec. 3,2024-- Samsung Biologics (KRX: 207940.KS),a global contract development and manufacturing organization (CDMO),today hosted its second Supplier ESG Day to share insights on

1 ... 675 676 677 678 679 680 681 ... 1247